Identification of biomarker candidates to predict response in the combination immunotherapy for gastric cancer

被引：0
|
作者：
Ohta, Shigeki [1 ,2 ]
Izawa, Naoki [3 ]
Misawa, Aya [1 ,2 ]
Katoh, Yuki [2 ]
Kubo, Akiko [4 ]
Kadowaki, Shigenori [5 ]
Minashi, Keiko [6 ]
Nishina, Tomohiro [7 ]
Eguchi, Takako Nakajima [3 ,8 ]
Kawakami, Yutaka [1 ,2 ]
机构：
[1] IUHW, Sch Med, Dept Immunol, Otawara, Tochigi, Japan
[2] Keio Univ, Sch Med, Inst Adv Med Res, Tokyo, Japan
[3] Sch Med, Dept Clin Oncol, Kawasaki, Kanagawa, Japan
[4] Keio Univ, Sch Med, Dept Chem, Tokyo, Japan
[5] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan
[6] Chiba Canc Ctr, Clin Trial Promot Dept, Chiba, Japan
[7] Shikoku Canc Ctr, Dept Gastrointestinal Med Oncol, Matsuyama, Ehime, Japan
[8] Kyoto Univ Hosp, Kyoto, Japan
来源：
CANCER SCIENCE | 2022年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P12-5-7
引用
收藏
页码：396 / 396
页数：1
相关论文
共 50 条
  • [21] DNA methylation-related lncRNAs predict prognosis and immunotherapy response in gastric cancer
    Guo, Xiong
    Wang, Yujun
    Zha, Lang
    Li, Hui
    Qian, Kun
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (16) : 14745 - 14760
  • [22] Identification of a candidate biomarker predictive of the response to allergen immunotherapy
    Bouley, J.
    Jain, K.
    Caillot, N.
    Mascarell, L.
    Lombardi, V
    Baron-Bodo, V
    Batard, T.
    Nony, E.
    Moingeon, P.
    ALLERGY, 2013, 68 : 177 - 178
  • [23] Diagnostic biomarker KIF23 is associated with immune infiltration and immunotherapy response in gastric cancer
    Bai, Maoshu
    Liu, Xin
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [24] Identification of glycogene signature as a tool to predict the clinical outcome and immunotherapy response in breast cancer
    Lin, Shuai
    Tan, Zengqi
    Cui, Hanxiao
    Ma, Qilong
    Zhao, Xuyan
    Wu, Jianhua
    Dai, Luyao
    Kang, Huafeng
    Guan, Feng
    Dai, Zhijun
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [25] Development of a signature to predict response to cancer immunotherapy
    Machlenkin, A.
    Straussman, R.
    Gure, A.
    Frankenburg, S.
    Smith, Y.
    Peretz, T.
    Lotem, M.
    TUMOR BIOLOGY, 2012, 33 : 22 - 22
  • [26] The differential proteome profile of stomach cancer: Identification of the biomarker candidates
    Jang, JS
    Cho, HY
    Lee, YJ
    Ha, WS
    Kim, HW
    ONCOLOGY RESEARCH, 2004, 14 (10) : 491 - 499
  • [27] PD-L1 as a Biomarker in Gastric Cancer Immunotherapy
    Cho, Yunjoo
    Ahn, Soomin
    Kim, Kyoung-Mee
    JOURNAL OF GASTRIC CANCER, 2025, 25 (01) : 177 - 191
  • [28] Identification of a Protein Kinase Activity Based Biomarker Fingerprint to Predict Response to Sunitinib, Sorafenib and Pazopanib in Scirrhous Gastric Cancer Cell Lines
    Koh, Y.
    Serizawa, M.
    de Wijn, R.
    Hilhorst, R.
    Nakajima, T.
    Yasui, H.
    Yanagihara, K.
    Dankers, M.
    Ruijtenbeek, R.
    Boku, N.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S175 - S175
  • [29] Identification of USP39 as a prognostic and predictive biomarker for determining the response to immunotherapy in pancreatic cancer
    Jiahui Yuan
    Beibei Xu
    Yongcheng Su
    Pingping Zhang
    Xianbin Zhang
    Peng Gong
    BMC Cancer, 25 (1)
  • [30] SLAMF8 can predict prognosis of pan-cancer and the immunotherapy response effectivity of gastric cancer
    Li, Guangyao
    Li, Qijiao
    Ping, Miaomiao
    Jiao, Ziying
    Wang, Xingxing
    Cheng, Juan
    Guo, Jizheng
    Cheng, Ya
    AGING-US, 2024, 16 (10): : 8944 - 8964
12345